ctDNA Tracks Relapse Risk in Breast Cancer - Top-Institutions - MDSpire

ctDNA Tracks Relapse Risk in Breast Cancer

June 9, 2026

The Pathologist

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

#1

Vanderbilt University Medical Center

Nashville, Tennessee
Key Differentiators
- Oncology
#2

National Taiwan University Hospital

Taipei, Taiwan
Key Differentiators
- Oncology
#3

Institut Jules Bordet

Brussels, Belgium
Key Differentiators
- Oncology
#4

Instituto Nazionale dei Tumori

Milan, Italy
Key Differentiators
- Oncology
#5

NYU Grossman School of Medicine

New York, New York
Key Differentiators
- Oncology

Original Source(s)

The Pathologist

ctDNA Tracks Relapse Risk in Breast Cancer

June 9, 2026

Related Content

Frontiers In Oncology

Case Report: Synaptophysin-positive SMARCA4-deficient undifferentiated thoracic tumour: a diagnostic pitfall with therapeutic implications

Frontiers In Immunology

25HC regulates the polarization of CD163+ macrophages in the immune microenvironment of triple-negative breast cancer through the interferon pathway

by Hongmei Zheng, Wenqin Huang, Panshi Zhang, Sudhanshu Bhushan, Xinhong Wu, Yalong Yang
May 28, 2026

Frontiers In Immunology

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients